BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26489728)

  • 21. Aspirin enhances protective effect of fish oil against thrombosis and injury-induced vascular remodelling.
    Gong Y; Lin M; Piao L; Li X; Yang F; Zhang J; Xiao B; Zhang Q; Song WL; Yin H; Zhu L; Funk CD; Yu Y
    Br J Pharmacol; 2015 Dec; 172(23):5647-60. PubMed ID: 25339093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prasugrel, a Platelet P2Y12 Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia.
    Ohno K; Tomizawa A; Mizuno M; Jakubowski JA; Sugidachi A
    J Am Heart Assoc; 2016 Apr; 5(4):e002889. PubMed ID: 27053057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of pharmacological PAI-1 inhibition on thrombus formation and neointima formation after arterial injury.
    Suzuki J; Ogawa M; Muto S; Yamaguchi Y; Itai A; Isobe M
    Expert Opin Ther Targets; 2008 Jul; 12(7):783-94. PubMed ID: 18554148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human thrombomodulin inhibits arterial neointimal hyperplasia after balloon injury.
    Li JM; Singh MJ; Itani M; Vasiliu C; Hendricks G; Baker SP; Hale JE; Rohrer MJ; Cutler BS; Nelson PR
    J Vasc Surg; 2004 May; 39(5):1074-83. PubMed ID: 15111864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery.
    Park SJ; Kim HS; Yang HM; Park KW; Youn SW; Jeon SI; Kim DH; Koo BK; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):885-91. PubMed ID: 14988093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reverse apolipoprotein A-I mimetic peptide R-D4F inhibits neointimal formation following carotid artery ligation in mice.
    Du L; Qu X; Zheng H; Li R; Wang J; Chen M; Zhao P; Zhang Z; Gong K
    Am J Pathol; 2013 May; 182(5):1932-9. PubMed ID: 23499549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
    Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
    Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of matrix metalloproteinase axis-induced neointimal growth.
    Guo L; Ning W; Tan Z; Gong Z; Li X
    J Mol Cell Cardiol; 2014 Jan; 66():116-25. PubMed ID: 24291441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between the efficacy of dual antiplatelet therapy and the development of in-stent neointimal hyperplasia in porcine coronary arteries.
    Hemetsberger R; Farhan S; Strehblow C; Sperker W; Pavo I; Petrasi Z; Hemetsberger H; Posa A; Huber K; Glogar D; Gyöngyösi M
    Coron Artery Dis; 2008 Dec; 19(8):635-43. PubMed ID: 19005299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resveratrol inhibits neointimal formation after arterial injury through an endothelial nitric oxide synthase-dependent mechanism.
    Breen DM; Dolinsky VW; Zhang H; Ghanim H; Guo J; Mroziewicz M; Tsiani EL; Bendeck MP; Dandona P; Dyck JR; Heximer SP; Giacca A
    Atherosclerosis; 2012 Jun; 222(2):375-81. PubMed ID: 22552115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological properties of YM-254890, a specific G(alpha)q/11 inhibitor, on thrombosis and neointima formation in mice.
    Kawasaki T; Taniguchi M; Moritani Y; Uemura T; Shigenaga T; Takamatsu H; Hayashi K; Takasaki J; Saito T; Nagai K
    Thromb Haemost; 2005 Jul; 94(1):184-92. PubMed ID: 16113802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis.
    Day SM; Duquaine D; Mundada LV; Menon RG; Khan BV; Rajagopalan S; Fay WP
    Circulation; 2003 May; 107(20):2601-6. PubMed ID: 12732602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipopolysaccharide augments venous and arterial thrombosis in the mouse.
    Wang X
    Thromb Res; 2008; 123(2):355-60. PubMed ID: 18448153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GR144053, a fibrinogen receptor antagonist, enhances the suppression of neointima formation by losartan, an angiotensin II receptor antagonist, in the injured carotid artery of hamster.
    Matsuno H; Kozawa O; Niwa M; Kaida T; Hayashi H; Uematsu T
    Br J Pharmacol; 1997 Nov; 122(6):1099-104. PubMed ID: 9480031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined effects of a factor Xa inhibitor YM466 and a GPIIb/IIIa antagonist YM128 on thrombosis and neointima formation in mice.
    Iwatsuki Y; Kawasaki T; Hayashi K; Moritani Y; Nii T; Miyata K
    Thromb Haemost; 2004 Dec; 92(6):1221-8. PubMed ID: 15583727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The herbal extract HMC05 inhibits neointima formation in balloon-injured rat carotid arteries: possible therapeutic implications of HMC05.
    Lee JW; Lee BS; Lee JY; Ku HJ; Jeon SR; Kim JY; Ban JM; Sung SH; Shin HM; Park JE
    J Ethnopharmacol; 2011 Jan; 133(1):168-76. PubMed ID: 20883768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries.
    Meng QH; Yang G; Yang W; Jiang B; Wu L; Wang R
    Am J Pathol; 2007 Apr; 170(4):1406-14. PubMed ID: 17392179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral everolimus inhibits intimal proliferation in injured carotid artery in rats.
    Wang XF; Shen DL; Zhao XY; Ning HJ; Feng RS; Zhang JY
    Chin Med J (Engl); 2013; 126(10):1906-12. PubMed ID: 23673108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dermatan sulfate and bone marrow mononuclear cells used as a new therapeutic strategy after arterial injury in mice.
    Godoy JA; Block DB; Tollefsen DM; Werneck CC; Vicente CP
    Cytotherapy; 2011 Jul; 13(6):695-704. PubMed ID: 21250866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model.
    Huang J; Driscoll EM; Gonzales ML; Park AM; Lucchesi BR
    J Pharmacol Exp Ther; 2000 Nov; 295(2):492-9. PubMed ID: 11046080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.